Page last updated: 2024-10-23

bendroflumethiazide and Infant, Newborn, Diseases

bendroflumethiazide has been researched along with Infant, Newborn, Diseases in 1 studies

Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.

Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
HARLEY, JD1
ROBIN, H1
ROBERTSON, SE1

Other Studies

1 other study available for bendroflumethiazide and Infant, Newborn, Diseases

ArticleYear
THIAZIDE-INDUCED NEONATAL HAEMOLYSIS?
    British medical journal, 1964, Mar-14, Volume: 1, Issue:5384

    Topics: Abnormalities, Drug-Induced; Anemia; Anemia, Hemolytic; Bendroflumethiazide; Chlorothiazide; Female;

1964